مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| تحلیل هزینه-اثربخشی در ارزیابی فناوری سلامت× | ارزیابی فناوری سلامت× | |
|---|---|---|
| حوزه | مدیریت خدمات سلامت | مدیریت خدمات سلامت |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 1996 | 1980 |
| پدیدآور≠ | Diane Meade Drummond, Michael Gold | International HTA organizations, National Institutes of Health |
| نوع≠ | Economic evaluation methodology | Structured assessment methodology |
| منبع بنیادین≠ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 | Goodman, C. S. (2004). HTA 101: Introduction to Health Technology Assessment (Version 1.0). National Library of Medicine, National Institutes of Health. link ↗ |
| نامهای دیگر | CEA, Cost-Effectiveness Analysis Healthcare | HTA, Technology Assessment Healthcare |
| مرتبط | 5 | 5 |
| خلاصه≠ | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. | Health Technology Assessment (HTA) is a structured, multidisciplinary approach to evaluating the clinical, economic, and societal effects of healthcare technologies (devices, drugs, procedures, systems). HTA synthesizes evidence from clinical trials, observational studies, and economic analyses to support decision-makers in adoption and reimbursement determinations. |
| ScholarGateمجموعهداده ↗ |
|
|